Cargando…
Complete Remission in a Child With Multisystem Inflammatory Syndrome and Stevens-Johnson Syndrome Treated With Infliximab
COVID-19, caused by SARS-CoV-2, can present with various dermatological manifestations, including (albeit rarely) severe mucocutaneous manifestations such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis. In contrast, multisystem inflammatory syndrome in children (MIS-C) commonly prese...
Autores principales: | Lootah, Shamma, Alshammari, Elaf, Alqanatish, Jubran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156146/ https://www.ncbi.nlm.nih.gov/pubmed/37153258 http://dx.doi.org/10.7759/cureus.37076 |
Ejemplares similares
-
Stevens-Johnson Syndrome Induced by Herbal Kadha
por: Lamture, Varsha Y, et al.
Publicado: (2023) -
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
Phenobarbital induced Stevens–Johnson syndrome in a child
por: Gaur, Sumit, et al.
Publicado: (2012) -
Stevens–Johnson syndrome and COVID-19: a case report with suspected multisystem inflammatory syndrome in children (MIS-C)
por: Ebrahimi, Mohsen, et al.
Publicado: (2023) -
Stevens-Johnson Syndrome Following Non-steroidal Anti-inflammatory Drugs: A Real-World Analysis of Post-marketing Surveillance Data
por: Shao, Qi-hui, et al.
Publicado: (2022)